Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
BMC Infectious Diseases
|
February 19, 2016
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center
Sandrine Roux, Florent Valour, Judith Karsenty, et al.
Annales Pharmaceutiques Francaises
|
October 25, 2024
Isavuconazole off-label use as an empirical treatment of invasive fungal infections
Anne-Lise Bienvenu, Chloe Gasser, Sophie Ducastelle-Lepretre, et al.
Open Forum Infectious Diseases
|
August 2, 2021
Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
Tristan Ferry, Anne Conrad, Eric Senneville, et al.
The Journal of Antimicrobial Chemotherapy
|
January 11, 2019
Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection
Romain Bricca, Sylvain Goutelle, Sandrine Roux, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2024
Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for <i>Candida</i> infections
Elodie Matusik, Olivia Vassal, Anne Conrad, et al.
Frontiers in Medicine
|
November 16, 2020
<i>Pseudomonas aeruginosa</i> Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
Matteo Cerioli, Cécile Batailler, Anne Conrad, et al.
Infectious Diseases Now
|
April 6, 2026
Efficacy and safety of dalbavancin as suppressive therapy in chronic implant-associated infections
Tomaso Beringheli, Céline Dupieux, Sylvain Goutelle, et al.
The Journal of Antimicrobial Chemotherapy
|
August 26, 2025
Peripheral neuropathy during long-term suppressive therapy with tedizolid: a case series
Tomaso Beringheli, Clément Javaux, Sandrine Roux, et al.
BMC Infectious Diseases
|
December 15, 2018
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity
Judith Provoost, Florent Valour, Delphine Gamondes, et al.
The Journal of Antimicrobial Chemotherapy
|
June 13, 2022
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
William Danjou, Paul Chabert, Thomas Perpoint, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
BMC Infectious Diseases
|
February 19, 2016
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center
Sandrine Roux, Florent Valour, Judith Karsenty, et al.
Annales Pharmaceutiques Francaises
|
October 25, 2024
Isavuconazole off-label use as an empirical treatment of invasive fungal infections
Anne-Lise Bienvenu, Chloe Gasser, Sophie Ducastelle-Lepretre, et al.
Open Forum Infectious Diseases
|
August 2, 2021
Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
Tristan Ferry, Anne Conrad, Eric Senneville, et al.
The Journal of Antimicrobial Chemotherapy
|
January 11, 2019
Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection
Romain Bricca, Sylvain Goutelle, Sandrine Roux, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2024
Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for <i>Candida</i> infections
Elodie Matusik, Olivia Vassal, Anne Conrad, et al.
Frontiers in Medicine
|
November 16, 2020
<i>Pseudomonas aeruginosa</i> Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
Matteo Cerioli, Cécile Batailler, Anne Conrad, et al.
Infectious Diseases Now
|
April 6, 2026
Efficacy and safety of dalbavancin as suppressive therapy in chronic implant-associated infections
Tomaso Beringheli, Céline Dupieux, Sylvain Goutelle, et al.
The Journal of Antimicrobial Chemotherapy
|
August 26, 2025
Peripheral neuropathy during long-term suppressive therapy with tedizolid: a case series
Tomaso Beringheli, Clément Javaux, Sandrine Roux, et al.
BMC Infectious Diseases
|
December 15, 2018
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity
Judith Provoost, Florent Valour, Delphine Gamondes, et al.
The Journal of Antimicrobial Chemotherapy
|
June 13, 2022
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
William Danjou, Paul Chabert, Thomas Perpoint, et al.
Page
of 3